论文部分内容阅读
灯盏花素注射液是从灯盏花中提取的黄酮类有效成分而制成的制剂,主要为黄酮、灯盏花乙素、灯盏花甲素,以灯盏花乙素为主。具有增加血流量、改善微循环、扩张血管、降低血液黏度、降血脂、促纤溶、抗血栓、抗血小板聚集等作用。临床上主要用于冠心病、脑梗死的治疗。本院遇1例灯盏花素注射液致严重不良反应,现报道如下。1临床资料患者,女,46岁,既往有高血压病史两年,不规则服药治疗,血压监测不详。两年前因甲状腺病在绍兴市人民医院手
Breviscapine injection is extracted from the Erigeron active ingredients in the preparation of flavonoids, mainly flavonoids, scutellarin, erigeron, scutellarin-based. With increased blood flow, improve microcirculation, dilate blood vessels, reduce blood viscosity, lipid-lowering, fibrinolysis, anti-thrombosis, anti-platelet aggregation and so on. Clinically for coronary heart disease, cerebral infarction treatment. The hospital case of a case of breviscapine injection caused serious adverse reactions, are reported below. 1 Clinical data Patients, female, 46 years old, with a history of previous hypertension for two years, irregular medication, blood pressure monitoring is unknown. Two years ago due to thyroid disease in Shaoxing People’s Hospital hand